Q1 2025 |
315 |
$1.21B |
+$90.1M |
-$351M |
-$261M |
GSK, JPM, UNP, GOOGL, AMZN
|
13F-HR |
4/9/2025, 07:53 AM |
Q4 2024 |
319 |
$1.41B |
+$18.4M |
-$23.9M |
-$5.51M |
GSK, MSFT, GOOGL, JPM, UNP
|
13F-HR |
1/13/2025, 11:18 AM |
Q3 2024 |
329 |
$1.53B |
+$29.9M |
-$54.5M |
-$24.6M |
GSK, MSFT, GOOGL, JPM, UNP
|
13F-HR |
10/18/2024, 06:40 AM |
Q2 2024 |
328 |
$1.5B |
+$20.5M |
-$24.2M |
-$3.72M |
GSK, MSFT, GOOGL, JPM, UNP
|
13F-HR |
7/16/2024, 12:26 PM |
Q1 2024 |
330 |
$1.57B |
+$393M |
-$52.8M |
+$340M |
GSK, MSFT, GOOGL, JPM, UNP
|
13F-HR |
4/19/2024, 10:46 AM |
Q4 2023 |
338 |
$1.1B |
+$12.1M |
-$73M |
-$61M |
GSK, MSFT, GOOGL, JPM, UNP
|
13F-HR |
1/16/2024, 06:08 AM |
Q3 2023 |
348 |
$1.07B |
+$103M |
-$47.7M |
+$55.4M |
GSK, MSFT, HLN, GOOGL, JPM
|
13F-HR |
10/10/2023, 07:34 AM |
Q2 2023 |
356 |
$1.05B |
+$95.7M |
-$16.9M |
+$78.9M |
GSK, HLN, MSFT, JPM, UNP
|
13F-HR |
7/19/2023, 09:54 AM |
Q1 2023 |
361 |
$942M |
+$2.94M |
-$255M |
-$252M |
GSK, HLN, JPM, UNP, EQT
|
13F-HR |
4/26/2023, 11:49 AM |
Q4 2022 |
390 |
$1.17B |
+$508M |
-$6.35M |
+$501M |
GSK, HLN, JPM, UNP, GOOGL
|
13F-HR |
1/18/2023, 10:05 AM |
Q3 2022 |
313 |
$600M |
+$310M |
-$7.25M |
+$302M |
GSK, HLN, JPM, UNP, GOOGL
|
13F-HR |
11/2/2022, 10:36 AM |
Q2 2022 |
294 |
$764M |
+$2.36M |
-$20.3M |
-$17.9M |
GSKXXXX, GOOGL, UNP, EEM, QQQ
|
13F-HR |
7/22/2022, 10:42 AM |
Q1 2022 |
304 |
$903M |
+$167M |
-$40.6M |
+$126M |
GSKXXXX, GOOGL, UNP, EEM, QQQ
|
13F-HR |
5/6/2022, 09:13 AM |
Q4 2021 |
307 |
$809M |
+$15.7M |
-$16.7M |
-$1.09M |
GSKXXXX, GOOGL, AMZN, UNP, EEM
|
13F-HR |
1/24/2022, 08:49 AM |
Q3 2021 |
309 |
$747M |
+$149M |
-$55.5M |
+$93.7M |
GSKXXXX, GOOGL, AMZN, UNP, EEM
|
13F-HR |
11/9/2021, 09:53 AM |
Q2 2021 |
298 |
$678M |
$0 |
$0 |
|
GSKXXXX, GOOGL, UNP, AMZN, EEM
|
13F-HR |
8/10/2021, 06:15 AM |